Case Report Links Ramucirumab Plus Docetaxel to Rare Non-Perforating Colitis
A clinical case report identifies rare early-onset non-perforating inflammatory colitis following ramucirumab plus docetaxel therapy in a lung cancer patient.
A clinical case report identifies rare early-onset non-perforating inflammatory colitis following ramucirumab plus docetaxel therapy in a lung cancer patient.
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.